Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

Medera announced that updated results from its ongoing MUSIC-HFpEF Phase 1/2a clinical trial investigating SRD-002, a one-time gene therapy ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

The prospect of Lyme disease is no joke. About 47% of the adult ticks that the St. Joseph County Department of Health has ...

Coldwater Creek snakes through Wedgewood, hugging the subdivision’s contours on its meandering 14-mile journey northeast from ...

Whatever the case, they're all high-performance American cars that maybe deserve to be remembered a bit better. Source: ...

Genetically modified mosquitoes have been released in the United States, taking flight in Florida. They are intended to ...

Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier ...

A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition ...

The following is a summary of "Association of triglyceride-glucose index trajectories with the risk of worsening heart ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...